Reply

Retina

Volumn 28, Issue 2, 2008, Pages 369-370

  Cohen, Steven M ^a,b  

^a Retina Vitreous Associates of Florida   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE ACETONIDE;

CELL FUNCTION; CLINICAL FEATURE; DIAGNOSTIC ERROR; DRUG EFFECT; EPIRETINAL MEMBRANE; EYE CARE; HUMAN; IDIOPATHIC JUXTAFOVEAL RETINAL TELANGIECTASIS; LETTER; MUELLER CELL; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; RETINA DISEASE; RISK FACTOR; SURGICAL RISK; TELANGIECTASIA; VISUAL IMPAIRMENT; VITRECTOMY;

EID: 43149114684     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31815ec444     Document Type: Letter

References (12)

1. Cohen SM, Cohen ML, El-Jabali F, Pautler SE. Optical coherence tomography finings in nonproliferative group 2a idiopathic juxtafoveal retinal telangiectasis. Retina 2007;27:59-66.
2. Shuman JS, Puliafito CA, Gujimoto JC. Optical Coherence Tomography of Ocular Diseases. 2nd ed. Thorofare, NJ: Slack, 2004;24:113-147.
3. Paunescu LA, Ko TH, Duker JS, et al. Idiopathic juxtafoveal retinal telangiectasis: new findings by ultrahigh-resolution optical coherence tomography. Ophthalmology 2006;113:48-57.
4. Gaudric A, Ducos de Lahitte G, Cohen SY, et al. Optical coherence tomography in group 2a idiopathic juxtafoveal retinal telangiectasis. Arch Ophthalmol 2006;124:1410-1419.
5. Yannuzzi LA, Bardal AMC, Freund KB, et al. Idiopathic macular telangiectasis. Arch Ophthalmol 2006;124:450-460.
6. Surguch V, Gamulescu MA, Gabel VP. Optical coherence tomography findings in idiopathic juxtafoveal retinal telangiectasis. Graefes Arch Clin Exp Ophthalmol 2007;245:783-788.
7. Dehghan MH, Ahmadieh H, Soheilian M, et al. Therapeutic effects of laser photocoagulation and/or vitrectomy in Eales' disease. Eur J Ophthalmol 2005;15:379-383.
8. Samuel MA, Equi RA, Chang TS, et al. Idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN): new observations and a proposed staging system. Ophthalmology 2007;114:1526-1529.
9. Rabena MD, Pieramici DJ, Castellarin AA, et al. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 2007;27:419-425.
10. Haritoglou C, Kook D, Neubauer A, et al. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 2006;26:999-1005.
11. Eichler W, Yafai Y, Wiedemann P, Reichenbach A. Angiogenesis-related factors derived from retinal glial (Muller) cells in hypoxia. Neuroreport 2004;15:1633-1637.
12. Gass JDM, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis: update of classification and follow-up study. Ophthalmology 1993;100:1536-1546.